Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Qualcomm plans new chip architecture for phones - Semafor
• HII opens 80,000 sq ft carrier overhaul facility at Newport News
• UN estimates 80 mines remain in Hormuz